期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

莽草酸对子囊霉素生物合成的影响 被引量：5

Effect of shikimic acid on the ascomycin biosynthesis
下载PDF
导出
摘要 研究了添加莽草酸前体物质对子囊霉素生物合成的影响。结果表明,发酵培养24h时添加0.15%的莽草酸,至96h发酵结束时子囊霉素发酵效价最高,可达131.7mg/L;与不添加前体物质相比,子囊霉素发酵效价提高了51%。
作者 穆云龙 余旭亚 孟庆雄 王洪钟
机构地区 昆明理工大学生命科学与技术学院 清华大学生物科学与技术系
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2008年第7期I0003-I0004,共2页 Chinese Journal of Antibiotics
关键词 子囊霉素 生物合成 莽草酸 前体
分类号 R979.5 [医药卫生—药品] R979.1 [医药卫生—药品]
  • 相关文献

参考文献9

  • 1Wallace K K, Reynolds K A. Biosynthetic studies of ascomycin (FK520) : Formation of the (1R, 3R,4R)-3,4- dihydroxycyclohexanecarboxylic acid-derived moiety [J]. J Am Chem Soc,1994,116(25):11600-11601.
  • 2Wilson D J, Patton S, Florova G, et al. The shikimie acid pathway and polyketide biosynthesis [J]. J Ind Microbiol Biotechnol, 1998,20 (5) : 299-303.
  • 3孙丽娟,黄捷.含氮大环内酯类免疫抑制剂的生物合成[J].海峡药学,2007,19(6):11-15. 被引量：2
  • 4Wu K, Chung L L, Revill W P, et al. The FK520 gene duster of Streptomyces hygroscopicus var. aseomyeetieus (ATCC 14891) contains genes for biosynthesis of unusual polyketide extender units [J]. Gene,2000,251:81-90.
  • 5Morisaki M, Arai T. Identity of immunosuppressant FR- 900520 with ascomycin [J]. J Antibiot, 1992,45 (1) : 126-128.
  • 6Kumar P, Shorma S K, Malriya H K, et al. An improved fermentation prosess for preparing ascomycin. WO, 2007029082 [P]. 2007-03-15.
  • 7Masakuni O, Tanak H, Goto T, et al. Method for inhibiting lymphokine production. US, 6201005B1 [P]. 2001-03- 13.
  • 8张育杰,胡海峰,朱宝泉.前体对洛伐他汀生物合成的影响[J].中国抗生素杂志,2006,31(9):529-531. 被引量：5
  • 9Reynolds K A, Wallace K K, Handa S, et al. Biosynthesis of the shikimate-derived starter unit of the immunosuppressant ascomycin:stereochemistry of the 1,4-conjugate elimination [J]. J Antibiot, 1997,50(8) : 701-703.

二级参考文献34

  • 1陈鹏,陈崇宏,程元荣.FKBPs的研究进展[J].海峡药学,2004,16(3):6-10. 被引量：2
  • 2孙宇辉,邓子新.聚酮化合物及其组合生物合成[J].中国抗生素杂志,2006,31(1):6-14. 被引量：25
  • 3Endo A, Kuroda M, Tsujita Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholestergenesis produced by Penicillium citrinum[ J ]. J Antibiot, 1976, 29(12): 1246
  • 4Endo A, Monacolin K. A new hypocholesterolemic agent produced by a Monascus species[J]. J Antibiot, 1979, 32(8):852
  • 5Alberts A W, Chen J, Kuron G, et al. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent[J]. Proc Natl Acad Sci USA, 1980, 77(7): 3957
  • 6Hendrickson L, Davis C R, Roach C. Lovastatin biosynthesis in Aspergillus terreus characterization of blocked mutants,enzyme activities and a multifunctional polyketide synthase gene[J]. Chem Biol, 1999, 6(7):429
  • 7Lai L S T, Pan C C, Tzeng B K. The influence of medium design on lovastatin production and pellet formation with a high-producing mutant of Aspergillus terreus in submerged cultures[J]. Process Biochem, 2003, 38(9): 1317
  • 8Casas Lopez J L, Sanchez Perez J A, Fernandez Sevilla J M,et al. Production of lovastatin by Aspergillus terreus: effects of the C: N ratio and the principal nutrients on growth and metabolite[J]. Enzyme Microb Technol, 2003, 33 (2 - 3): 270
  • 9Kumar M S, Jana S K, Senthil V, et al. Repeated fed-batch process for improving lovastatin production [J]. Process Biochem, 2000, 36(4): 363
  • 10kino T,Hatanaka H,Hashimoto M,et al.FK506,a novel immunosuppressant isolated from a streptomyces[J].J Antibiot (Tokyo),1987,40:1249 ～ 1255

共引文献5

同被引文献41

  • 1Masakuni Okuhazu, HannLa, Toshi Goto, et al. Tricyclo compounds, a process for their production and pharmaceutical composition containing the same: US, 4894366 [P]. 1990-01-16.
  • 2Arai T, Kouama Y, Suenage T, et al. Ascomycin, an antifungal antibiotic [J]. J. Antibiotics, 1962, 15: 231-232.
  • 3Wang-Fana Weizheng, Kustersa E, Lohsea O, et al. Application of centrifugal counter-current chromatography to the separation of macrolide antibiotic analogues I . Selection of solvent systems based on solubility and partition coefficient investigations [J]. Journal of Chromatography A, 1999, 864: 69-76.
  • 4Schnopp C, Remling R, Mohrenschlager M, et al. Topical taerolimus (FK506) and mometasone furoate in treatment of dyshidrotie palmar eczema: a randomized, observer blinded trial [J]. J. Am. Acad. Dermatol., 2002, 46 (1): 73-76.
  • 5Ruzicka T, Assmann T, Homey B Tacrolimus. The drug for the turn of the millennium [J]. J. Am. Arch. Dermatol., 1999, 135 (5): 574-580.
  • 6Schreiber S L, Crabtree G R. The mechanism of action of cyclosporing A and FK506 [J].Immunol Today, 1992, 13 (4): 136-142.
  • 7Panhans-Gross A, Novak N, Kraft S, et al. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506) [J]. J. Allergy Clin Immunol, 2001, 107 (2):345-352.
  • 8Stuetz A, Grassberger M, Meingassner J G.Pimecrolimus (Elidel, SDZ, ASM981 )preclinical pharmacologic profile and skin selectivity [J].Semi. Cutan Med. Surg., 2001, 20 (4): 233-241.
  • 9Boguniewicz M, Leung D Y. Pathophysiologic mechanisms in atopic dermatitics[J]. Semin Cutan Med. Surg., 2001, 20 (4): 217-225.
  • 10清华大学国际技术转移中心.子囊霉素菌种及工艺概要[EB/OL] [2008-07-07]. http://www.ittc.com.cn/view.asp?cat0_id=2&cat1_id=12&id=2610.

引证文献5

二级引证文献13

中国抗生素杂志
2008年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部